MapLight Therapeutics, Inc. (MPLT) insider trading.
In Q3 2026, insiders at MapLight Therapeutics, Inc. reported 59 non-derivative transactions on 17 Forms 3, 4 and 5: 6 open-market purchases worth $65.5M and 46 sales worth $11.6M.
- Transactions
- 59
- Purchases (P)
- 6
- Sales (S)
- 46
- Net shares, P minus S
- 5,283,419
- Insiders
- 8
- Last filed
- 2026-09-18
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Foff Erin Pennock | Officer · Chief Medical Officer | 10 | 0 | 9 |
| Hanson Kristopher | Officer · General Counsel | 9 | 0 | 8 |
| Gillis Jonathan | Officer · CAO and Interim CFO | 9 | 0 | 7 |
| Lillie James Woodruff | Officer · Chief Scientific Officer | 9 | 0 | 8 |
| Kroeger Christopher A. | Director, Officer · Chief Executive Officer | 8 | 0 | 7 |
| Kreitzer Anatol | Officer · Chief Discovery Officer | 8 | 0 | 7 |
| Catalyst4, Inc. | TenPercentOwner | 5 | 5 | 0 |
| Cox Troy | Director | 1 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Hanson Kristopher | S (D) | 16,509 | $11.67 | 137,044 | Form 4 |
| 2026-08-17 | Kroeger Christopher A. | A (A) | 23,145 | $0 | 1,269,600 | Form 4 |
| 2026-08-17 | Gillis Jonathan | A (A) | 6,020 | $0 | 150,260 | Form 4 |
| 2026-08-17 | Gillis Jonathan | A (A) | 2,222 | $0 | 152,482 | Form 4 |
| 2026-08-17 | Lillie James Woodruff | A (A) | 7,730 | $0 | 210,110 | Form 4 |
| 2026-08-17 | Hanson Kristopher | A (A) | 7,730 | $0 | 153,553 | Form 4 |
| 2026-08-17 | Foff Erin Pennock | A (A) | 13,360 | $0 | 312,261 | Form 4 |
| 2026-08-17 | Kreitzer Anatol | A (A) | 6,020 | $0 | 180,926 | Form 4 |
| 2026-08-14 | Catalyst4, Inc. | P (A) | 4,400,000 | $11.38 | 25,306,689 | Form 4 |
| 2026-08-03 | Lillie James Woodruff | S (D) | 22,082 | $12.54 | 202,380 | Form 4 |
| 2026-07-30 | Catalyst4, Inc. | P (A) | 1,000,000 | $13 | 20,906,689 | Form 4 |
| 2026-07-29 | Catalyst4, Inc. | P (A) | 3,000 | $12.63 | 19,906,689 | Form 4 |
| 2026-07-28 | Catalyst4, Inc. | P (A) | 65,137 | $11.69 | 19,903,689 | Form 4 |
| 2026-07-28 | Catalyst4, Inc. | P (A) | 141,088 | $10.74 | 19,838,552 | Form 4 |
| 2026-07-28 | Cox Troy | P (A) | 15,620 | $9.52 | 15,620 | Form 4 |
| 2026-07-17 | Gillis Jonathan | S (D) | 600 | $36.51 | 162,109 | Form 4 |
| 2026-07-17 | Gillis Jonathan | S (D) | 16,969 | $37.61 | 145,140 | Form 4 |
| 2026-07-17 | Gillis Jonathan | S (D) | 900 | $38.17 | 144,240 | Form 4 |
| 2026-07-17 | Kreitzer Anatol | S (D) | 200 | $38.39 | 174,906 | Form 4 |
| 2026-07-17 | Kreitzer Anatol | S (D) | 14,140 | $37.7 | 175,106 | Form 4 |
| 2026-07-17 | Kreitzer Anatol | S (D) | 2,833 | $37.05 | 189,246 | Form 4 |
| 2026-07-17 | Kroeger Christopher A. | S (D) | 16,779 | $37.9 | 1,246,455 | Form 4 |
| 2026-07-17 | Lillie James Woodruff | S (D) | 2,077 | $37.9 | 224,462 | Form 4 |
| 2026-07-17 | Hanson Kristopher | S (D) | 1,130 | $37.9 | 145,823 | Form 4 |
| 2026-07-17 | Foff Erin Pennock | S (D) | 3,656 | $37.9 | 298,901 | Form 4 |
| 2026-07-16 | Gillis Jonathan | S (D) | 6,979 | $36.66 | 164,185 | Form 4 |
| 2026-07-16 | Gillis Jonathan | S (D) | 1,476 | $37.44 | 162,709 | Form 4 |
| 2026-07-16 | Kreitzer Anatol | S (D) | 1,592 | $37.44 | 192,079 | Form 4 |
| 2026-07-16 | Kreitzer Anatol | S (D) | 7,464 | $36.66 | 193,671 | Form 4 |
| 2026-07-16 | Kroeger Christopher A. | S (D) | 28,091 | $37.26 | 1,263,326 | Form 4 |
| 2026-07-16 | Kroeger Christopher A. | S (D) | 92 | $37.96 | 1,263,234 | Form 4 |
| 2026-07-16 | Kroeger Christopher A. | S (D) | 40,899 | $36.46 | 1,291,417 | Form 4 |
| 2026-07-16 | Lillie James Woodruff | S (D) | 12 | $37.96 | 226,539 | Form 4 |
| 2026-07-16 | Lillie James Woodruff | S (D) | 3,526 | $37.26 | 226,551 | Form 4 |
| 2026-07-16 | Lillie James Woodruff | S (D) | 5,009 | $36.45 | 230,077 | Form 4 |
| 2026-07-16 | Hanson Kristopher | S (D) | 3,331 | $37.26 | 146,964 | Form 4 |
| 2026-07-16 | Hanson Kristopher | S (D) | 4,776 | $36.45 | 150,295 | Form 4 |
| 2026-07-16 | Hanson Kristopher | S (D) | 11 | $37.96 | 146,953 | Form 4 |
| 2026-07-16 | Foff Erin Pennock | S (D) | 19 | $37.96 | 302,557 | Form 4 |
| 2026-07-16 | Foff Erin Pennock | S (D) | 5,865 | $37.26 | 302,576 | Form 4 |
| 2026-07-16 | Foff Erin Pennock | S (D) | 9,163 | $36.46 | 308,441 | Form 4 |
| 2026-07-15 | Gillis Jonathan | S (D) | 5,356 | $36.13 | 175,863 | Form 4 |
| 2026-07-15 | Gillis Jonathan | S (D) | 4,699 | $36.94 | 171,164 | Form 4 |
| 2026-07-15 | Kreitzer Anatol | S (D) | 4,510 | $36.94 | 201,135 | Form 4 |
| 2026-07-15 | Kreitzer Anatol | S (D) | 5,545 | $36.13 | 205,645 | Form 4 |
| 2026-07-15 | Kroeger Christopher A. | S (D) | 18,950 | $36 | 1,375,144 | Form 4 |
| 2026-07-15 | Kroeger Christopher A. | S (D) | 42,738 | $36.99 | 1,332,406 | Form 4 |
| 2026-07-15 | Kroeger Christopher A. | S (D) | 90 | $37.54 | 1,332,316 | Form 4 |
| 2026-07-15 | Lillie James Woodruff | S (D) | 5,393 | $36.99 | 235,098 | Form 4 |
| 2026-07-15 | Lillie James Woodruff | S (D) | 12 | $37.54 | 235,086 | Form 4 |
| 2026-07-15 | Lillie James Woodruff | S (D) | 2,238 | $36 | 240,491 | Form 4 |
| 2026-07-15 | Hanson Kristopher | S (D) | 5,103 | $36.99 | 155,081 | Form 4 |
| 2026-07-15 | Hanson Kristopher | S (D) | 2,147 | $36 | 160,184 | Form 4 |
| 2026-07-15 | Hanson Kristopher | S (D) | 10 | $37.54 | 155,071 | Form 4 |
| 2026-07-15 | Foff Erin Pennock | S (D) | 4,465 | $36 | 326,594 | Form 4 |
| 2026-07-15 | Foff Erin Pennock | S (D) | 8,972 | $36.99 | 317,622 | Form 4 |
| 2026-07-15 | Foff Erin Pennock | S (D) | 7,845 | $37.04 | 331,059 | Form 4 |
| 2026-07-15 | Foff Erin Pennock | S (D) | 7,155 | $36.16 | 338,904 | Form 4 |
| 2026-07-15 | Foff Erin Pennock | S (D) | 18 | $37.54 | 317,604 | Form 4 |
Transaction codes in this quarter
Get MPLT insider transactions through the API
Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1770069&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · MPLT company page · MapLight Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling MapLight Therapeutics, Inc. (MPLT)?
In Q3 2026, insiders at MapLight Therapeutics, Inc. reported 59 non-derivative transactions on 17 Forms 3, 4 and 5: 6 open-market purchases worth $65.5M and 46 sales worth $11.6M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these MapLight Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.
Plain-text version for agents and LLMs: /insider-trading/mplt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.